Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs

Of the approximately 35 million Americans who have diabetes (Types 1 and 2), about a third require insulin to manage their disease. For diabetic patients, out-of-pocket costs for insulin can be a major expense, whether they are insured in the commercial market, enrolled in Medicare, or un- and underinsured.